ePRO/eCOA White Papers & Case Studies

  1. Streamlined Deployment And Patient Data Collection 7/31/2025

    Navigate the inherent complexities, infinite variables, and constant changes that define life-sustaining studies with confidence using a patient-centric platform.

  2. Insights Into The Potential Of eClinical Solutions 7/31/2025

    How are eClinical technologies—specifically IRT and eCOA— being leveraged to overcome patient recruitment difficulties, high mortality rates, and the intricacies of cancer treatments.

  3. Solutions For Clinical Trials: Trusted ECG Data For Faster, More Flexible Trials 7/30/2025

    With FDA-cleared 6-lead and 12-lead handheld devices, this platform offers remote and onsite flexibility, enabling fast, accurate, and auditable ECG data capture tailored to diverse trial designs.

  4. Why Customers Are Switching To Medidata CTMS And eTMF 7/17/2025

    Discover a CTMS that leads the market with top rankings and offers unmatched integration, automation, and user experience for faster, more efficient clinical trial execution.

  5. Reliable Endpoints Powering Successful Signal Detection 7/15/2025

    With over two decades of proven experience in trials requiring complex clinician ratings, Rater Station helps sponsors overcome the challenges of subjective outcome measures and optimize signal detection.

  6. Accelerating CRO Study Deployment At Scale 7/7/2025

    A top-3 CRO and a top-10 pharmaceutical company partnered with Medable to help accelerate, scale, and standardize their eCOA trials. See how they accomplished it.

  7. eSource Purpose Is Not Just To Complete The EDC 7/7/2025

    Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.

  8. Powering Urologic Research With Exclusive Real-World Data 6/25/2025

    These high-quality, fit-for-purpose data modules are tailored to conditions such as prostate cancer, benign prostatic hyperplasia (BPH), non-muscle invasive bladder cancer (NMIBC), and more.

  9. How Sponsors Can Drive Success With Central eSource At Investigator Sites 6/17/2025

    Centralized eSource systems enable complex clinical trials to align with key regulatory frameworks, including ICH E6(R3), ICH E8(R1), and 21 CFR 312, to meet the highest standards of GCP.

  10. Optimizing EDC Strategy And Data Collection for a Rare Disease Trial 6/11/2025

    Explore how Veristat created a forward-looking roadmap for EDC and CRFs integration for a small biotech sponsor, ensuring a future-ready data ecosystem without overcomplicating current operations.